Ironwood Pharma (IRWD) Misses Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall St set for lower open as Middle East clashes revive rate-hike speculation
- The Warsh pivot markets didn't expect
- Oil rises over 2% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
- GameStop posts higher income despite revenue drop in Q2 2026
- At least eight die, 18 missing after ferry capsizes off North Cyprus
- Manhunt underway after woman killed, several injured at Swiss rave shooting
- Aon close to acquiring USI Insurance from KKR in $17 billion deal, WSJ reports
- RedHill sells Talicia to Apotex for $18M upfront plus milestones
Ironwood Pharma (IRWD) to Resume Trading at 8:30 am ET
May 1, 2018 8:20 AM EDTIronwood Pharma (NASDAQ: IRWD) to Resume Trading at 8:30 am ET
... MoreIronwood Pharma (IRWD) to Separate Soluble Guanylate Cyclase Business from Commercial and Gastrointestinal Business
May 1, 2018 8:00 AM EDTIronwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial biotech company, today announced that its Board of Directors has authorized an intent to separate into two independent, publicly traded companies (Ironwood and R&D Co.). The separation is expected to be completed in the first half of 2019 and is anticipated to be tax-free to Ironwood shareholders.
... More
Ironwood Pharma (IRWD) Halted, News Pending
May 1, 2018 7:50 AM EDTIronwood Pharma (NASDAQ: IRWD) Halted, News Pending
... More